"Finally, let us never again accept a situation where the suffering of cancer patients is belittled, disease advocacy groups are gagged or controlled, and journalists are banned and their communications tracked," said journalist and advocate Rachel Smalley.
'The door is finally ajar to initiate some much-needed CEO-led reforms at our drug-buying agency'
March 3, 2025 Latest NewsBioPharmaComment
Latest Video
New Stories
-
NDIS keeps growing but signs emerge that reforms are starting to work
July 17, 2025 - - Latest News -
USTR launches new investigation, with minimal ambition on pharmaceuticals
July 17, 2025 - - Latest News -
New Zealand starting to benefit after lifting advertising prohibition
July 17, 2025 - - Latest News -
Mark Butler restates support for health technology assessment reform
July 16, 2025 - - Latest News -
Brandon BioCatalyst welcomes the inclusion of its CUREator in new program
July 16, 2025 - - Australian Biotech -
Cancer Australia launches research program targeting early-onset cancers
July 16, 2025 - - Latest News -
Imugene completes significant placement and launches share purchase plan
July 16, 2025 - - Australian Biotech